Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alcon AG (ALC) vs Levi Strauss & Co. (LEVI) Price & Performance

Levi Strauss & Co.Trade

Price performance (Past 24H)

Key statistics

Alcon AG vs Levi Strauss & Co. — how do they compare? Alcon AG trades at $74.19 (market cap $36.44B), while Levi Strauss & Co. trades at $22.95 (market cap $8.75B). The key difference: Alcon AG is far larger — about 4.2× Levi Strauss & Co.'s market cap, and Levi Strauss & Co. pays the higher dividend (2.81%). Which is the better fit depends on your goals.

ALCLEVI
Market Cap
$36.44B$8.75B
Sector
HealthConsumer Cyclical
52-Week High
$90.12$25.53
52-Week Low
$62.02$17.92
Enterprise Value
$40.28B$10.07B
Dividend Yield
0.48%2.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alcon AG

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Read more on ALC

About Levi Strauss & Co.

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver

Read more on LEVI